| Market Cap | 4.55B 3.91B 3.68B 3.36B 6.28B 433B 6.3B 43.58B 16.85B 221B 17.08B 16.71B 698B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.04B 3.8B 3.47B 6.48B 447B 6.51B 45.01B 17.4B 228B 17.64B 17.26B 721B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : Amicus Therapeutics
| 1 day | +1.57% |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 2026-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.57% | +1.65% | - | - | 4.55B | |
| -3.24% | -6.89% | -5.65% | +11.20% | 48.01B | |
| +0.17% | -1.04% | +405.80% | +546.58% | 44.44B | |
| -0.86% | -0.53% | +36.92% | +20.35% | 42.67B | |
| -0.14% | -2.13% | +1.31% | +82.21% | 39.96B | |
| 0.00% | -2.61% | +13.09% | +42.33% | 32.75B | |
| -3.44% | +0.22% | - | - | 17.74B | |
| -0.78% | +0.53% | +19.14% | +116.26% | 16.49B | |
| -0.37% | -0.87% | +10.98% | +30.93% | 14.38B | |
| -0.86% | -1.41% | +71.82% | +39.36% | 13.4B | |
| Average | -0.80% | -0.53% | +69.18% | +111.15% | 29.98B | |
| Weighted average by Cap. | -1.00% | -1.10% | +84.31% | +131.92% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 454M 428M 390M 729M 50.26B 732M 5.06B 1.96B 25.61B 1.98B 1.94B 81.03B | 634M 545M 513M 468M 875M 60.33B 878M 6.07B 2.35B 30.75B 2.38B 2.33B 97.28B |
| Net income | -56.11M -48.21M -45.42M -41.4M -77.4M -5.34B -77.72M -537M -208M -2.72B -211M -206M -8.61B | -27.11M -23.29M -21.95M -20.01M -37.4M -2.58B -37.55M -260M -100M -1.31B -102M -99.57M -4.16B |
| Net Debt | 194M 166M 157M 143M 267M 18.43B 268M 1.86B 717M 9.39B 727M 711M 29.71B | 149M 128M 120M 110M 205M 14.16B 206M 1.43B 551M 7.22B 559M 547M 22.83B |
Employees
-
